GlassScriptPhysician profile
Kathy Chauvin
NPI 1568422145
$686.77
in general payments reported to CMS, 2019-2025
10 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.33 · 2021: $117 · 2022: $212 · 2023: $152 · 2024: $71.37 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $277.22 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $173.65 | 2021-2024 | Dupixent |
| Optinose US, INC. | $65.55 | 2021 | |
| Stryker Corporation | $54.82 | 2022-2025 | Xpress Loprofile |
| Acera Surgical, INC. | $42.70 | 2025 | Restrata Wound Matrix |
| Hikma Pharmaceuticals USA | $16.68 | 2024 | Ryaltris |
| Itamar Medical INC | $14.71 | 2024 | Watchpatone |
| Astrazeneca Pharmaceuticals LP | $14.54 | 2021 | |
| Alk-Abello, INC | $14.01 | 2022 | |
| Glaxosmithkline, LLC. | $12.89 | 2023 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathy Chauvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.